Methods and compositions for synthesis of two-photon cleavable phosphoramidite molecules for oligonucleotide conjugation
US-11938187-B2 · Mar 26, 2024 · US
Drug delivery composition
US2016136286A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016136286-A1 |
| Application number | US-201615005127-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jan 25, 2016 |
| Priority date | Jun 6, 2008 |
| Publication date | May 19, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
There is provided a non-water soluble drug delivery composition comprising a conjugate and a polymer matrix wherein exposure of the composition to electromagnetic radiation at a suitable pre-determined wavelength and intensity induces release of the active ingredient from the composition. The conjugate is attached to the polymer matrix through non-covalent interactions. There is also provided a drug delivery apparatus formed from the drug delivery composition.
First claim
Opening claim text (preview).
1 . A non-water soluble drug delivery composition comprising; a conjugate and a polymer matrix, said conjugate comprising an active ingredient bonded to a protecting group; wherein exposure of the composition to electromagnetic radiation at a suitable pre-determined wavelength and intensity induces release of the active ingredient from the composition; wherein the polymer matrix is formed from one or more copolymer compounds; and wherein the, or one of the, copolymer compounds comprises t…
Assignees
Inventors
Classifications
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016136286A1 cover?
- There is provided a non-water soluble drug delivery composition comprising a conjugate and a polymer matrix wherein exposure of the composition to electromagnetic radiation at a suitable pre-determined wavelength and intensity induces release of the active ingredient from the composition. The conjugate is attached to the polymer matrix through non-covalent interactions. There is also provided a…
- Who is the assignee on this patent?
- Univ Belfast
- What technology area does this patent fall under?
- Primary CPC classification A61K47/54. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu May 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).